Market Overview

Morning Market Movers

Share:

IsoRay (NYSE: ISR) shares gained 26.67% to $3.23 as the company announced first pediatric Cesium-131 seeded mesh treatment for metastatic Wilms tumor.

BG Medicine (NASDAQ: BGMD) climbed 24.25% to $2.10 after the company reported narrower-than-expected Q4 loss and reported the issuance of patent covering Galectin-3.

Synta Pharmaceuticals (NASDAQ: SNTA) shares jumped 12% to $5.32 on positive interim results from the ENCHANT-1 trial of ganetespib in metastatic breast cancer.

Magnegas (NASDAQ: MNGA) gained 11.20% to $1.39 after the company reported that it has been selected for four demolition projects.

Burlington Stores (NYSE: BURL) shares jumped 11.04% to $28.76 on Q4 results. Burlington Stores reported its Q4 earnings of $1.07 per share, versus analysts' estimates of $1.03 per share.

Sinovac Biotech (NASDAQ: SVA) climbed 7.69% to $7.42 after the company reported unaudited Q4 results. Sinovac Biotech posted its quarterly net income of $5.8 million, or $0.10 per share, versus a year-ago net loss of $4.6 million, or $0.08 per share.

Herman Miller (NASDAQ: MLHR) shares jumped 6.58% to $30.60 after the company reported in-line FQ3 adjusted earnings. The company expected Q4 earnings of $0.43 to $0.47 per share on revenue of $485 million to $505 million. However, analysts were projecting earnings of $0.43 per share on revenue of $487.5 million.

Eagle Pharmaceuticals (NASDAQ: EGRX) shares jumped 4.01% to $15.06 on announcement of the NDA for Ryanodex being accepted by the US FDA with a priority review.

 

Related Articles (ISR + BGMD)

View Comments and Join the Discussion!

Posted-In: market moversNews Intraday Update Markets Movers

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com